Literature DB >> 28214365

Peripheral blood leucocytes show differential expression of tumour progression-related genes in colorectal cancer patients who have a postoperative intra-abdominal infection: a prospective matched cohort study.

S Alonso1, X Mayol1, L Nonell2, S Salvans1, M Pascual1, M Pera1.   

Abstract

AIM: Anastomotic leak is associated with higher rates of recurrence after surgery for colorectal cancer. However, the mechanisms responsible are unknown. We hypothesized that the infection-induced inflammatory response may induce overexpression of tumour progression-related genes in immune cells. The aim was to investigate the effect of postoperative intra-abdominal infection on the gene expression patterns of peripheral blood leucocytes (PBL) after surgery for colorectal cancer.
METHOD: Prospective matched cohort study. Patients undergoing surgery for colorectal cancer were included. Patients who had anastomotic leak or intra-abdominal abscess were included in the infection group (n = 23) and matched with patients without complications for the control group (n = 23). PBL were isolated from postoperative blood samples. Total RNA was extracted and hybridized to the Affymetrix Human Gene 1.0 ST microarray.
RESULTS: Patients in the infection group displayed 162 upregulated genes and 146 downregulated genes with respect to the control group. Upregulated genes included examples coding for secreted cytokines involved in tumour growth and invasion (S100P, HGF, MMP8, MMP9, PDGFC, IL1R2). Infection also upregulated some proangiogenic genes (CEP55, TRPS1) and downregulated some inhibitors of angiogenesis (MME, ALOX15, CXCL10). Finally, some inhibitors (HP, ORM1, OLFM4, IRAK3) and activators (GNLY, PRF1, FGFBP2) of antitumour immunity were upregulated and downregulated, respectively, suggesting that the inflammatory environment caused by a postoperative infection favours immune evasion mechanisms of the tumour.
CONCLUSION: Analysis of PBL shows differential expression of certain tumour progression-related genes in colorectal cancer patients who have a postoperative intra-abdominal infection, which in turn may promote the growth of residual cancer cells to become recurrent tumours. Colorectal Disease
© 2017 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Colorectal cancer; intra-abdominal infection; microarrays; peripheral blood leucocytes; surgery; tumour recurrence

Mesh:

Substances:

Year:  2017        PMID: 28214365     DOI: 10.1111/codi.13635

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.

Authors:  P Sánchez-Velázquez; M Pera; M Jiménez-Toscano; X Mayol; X Rogés; L Lorente; M Iglesias; M Gallén
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

2.  Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets.

Authors:  Anne Monette; Antigoni Morou; Nadia A Al-Banna; Louise Rousseau; Jean-Baptiste Lattouf; Sara Rahmati; Tomas Tokar; Jean-Pierre Routy; Jean-François Cailhier; Daniel E Kaufmann; Igor Jurisica; Réjean Lapointe
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

3.  Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.

Authors:  María Marcuello; Xavier Mayol; Eloísa Felipe-Fumero; Jaume Costa; Laia López-Hierro; Silvia Salvans; Sandra Alonso; Marta Pascual; Luís Grande; Miguel Pera
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

Review 4.  Matrix metalloproteinase-9 in relation to patients with complications after colorectal surgery: a systematic review.

Authors:  Pim Edomskis; Max R Goudberg; Cloë L Sparreboom; Anand G Menon; Albert M Wolthuis; Andre D'Hoore; Johan F Lange
Journal:  Int J Colorectal Dis       Date:  2020-08-31       Impact factor: 2.571

5.  Transcriptomic Biomarker Signatures for Discrimination of Oral Cancer Surgical Margins.

Authors:  Simon A Fox; Michael Vacher; Camile S Farah
Journal:  Biomolecules       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.